Literature DB >> 24750153

Development and progression of colorectal cancer based on follow-up analysis.

Takashi Hisabe1, Fumihito Hirai, Toshiyuki Matsui.   

Abstract

Elucidating the pathway of colorectal cancer development and progression can lead to identification of lesions that must be treated appropriately. The aim of the present review was to summarize the development and progression of colorectal cancer based on radiological and endoscopic follow-up analyses. These studies revealed several characteristic findings, including that initial morphology with progression to advanced cancer was most commonly 0-Is, followed by 0-IIa. Based on the doubling time, 0-Ip grew slowly in comparison with other morphologies. The observation period from adenomas measuring <10 mm to intramucosal cancers was more than 5 years. This makes it difficult to draw any accurate conclusions about the natural history of colorectal cancer based on follow-up observation alone and it is difficult to exclude the selection bias because of the difficulty of follow up for flat and depressed tumor. However, the only reliable way to elucidate the natural history is to accumulate cases.
© 2014 The Authors. Digestive Endoscopy © 2014 Japan Gastroenterological Endoscopy Society.

Entities:  

Keywords:  colorectal cancer; development; follow up; natural history; retrospective analysis

Mesh:

Year:  2014        PMID: 24750153     DOI: 10.1111/den.12276

Source DB:  PubMed          Journal:  Dig Endosc        ISSN: 0915-5635            Impact factor:   7.559


  7 in total

Review 1.  Molecular markers for colorectal cancer screening.

Authors:  Brandon T Dickinson; John Kisiel; David A Ahlquist; William M Grady
Journal:  Gut       Date:  2015-05-20       Impact factor: 23.059

2.  Early Detection and Recurrence of Colorectal Adenomas by Combination of Eight Cancer-Associated Biomarkers in Plasma.

Authors:  Louise Rasmussen; Hans Jørgen Nielsen; Ib Jarle Christensen
Journal:  Clin Exp Gastroenterol       Date:  2020-08-13

3.  Negative Impact of COVID-19 Associated Health System Shutdown on Patients Diagnosed With Colorectal Cancer: A Retrospective Study From a Large Tertiary Center in Ontario, Canada.

Authors:  Catherine L Forse; Stephanie Petkiewicz; Iris Teo; Bibianna Purgina; Kristina-Ana Klaric; Tim Ramsay; Jason K Wasserman
Journal:  J Can Assoc Gastroenterol       Date:  2021-12-16

4.  COVID-19 Impact on Diagnosis and Staging of Colorectal Cancer: A Single Tertiary Canadian Oncology Center Experience.

Authors:  Mathias Castonguay; Rola El Sayed; Corentin Richard; Marie-France Vachon; Rami Nassabein; Danielle Charpentier; Mustapha Tehfé
Journal:  Curr Oncol       Date:  2022-05-04       Impact factor: 3.109

5.  Patients with Non-Hodgkin's Lymphoma Are at Risk of Adenomatous Colon Polyps.

Authors:  Hamzah Abu-Sbeih; Ellie Chen; Osman Ahmed; Niharika Mallepally; Phillip Lum; Wei Qiao; Hun Ju Lee; Robert Bresalier; Lan Sun Wang; Brian Weston; Gottumukkala S Raju; Yinghong Wang
Journal:  Dig Dis Sci       Date:  2019-05-03       Impact factor: 3.199

Review 6.  The Role of Imaging in Health Screening: Overview, Rationale of Screening, and Screening Economics.

Authors:  David H Ballard; Kirsteen R Burton; Nikita Lakomkin; Shannon Kim; Prabhakar Rajiah; Midhir J Patel; Parisa Mazaheri; Gary J Whitman
Journal:  Acad Radiol       Date:  2020-05-12       Impact factor: 3.173

7.  Aspirin, ibuprofen, and reduced risk of advanced colorectal adenoma incidence and recurrence and colorectal cancer in the PLCO Cancer Screening Trial.

Authors:  Kenechukwu Chudy-Onwugaje; Wen-Yi Huang; L Joseph Su; Mark P Purdue; Christine C Johnson; Lingxiao Wang; Hormuzd A Katki; Kathryn Hughes Barry; Sonja I Berndt
Journal:  Cancer       Date:  2021-05-11       Impact factor: 6.921

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.